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Donor PTX3 polymorphisms were shown to inﬂuence the
risk of invasive aspergillosis among hematopoietic stem cell
transplant recipients. Here, we show that PTX3 polymor-
phisms are independent risk factors for invasive mold infec-
tions among 1101 solid organ transplant recipients, thereby
strengthening their role in mold infection pathogenesis and
patients’ risk stratiﬁcation.
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Invasive mold infections (IMIs) represent an important cause
of morbidity and mortality in transplant recipients [1, 2].
Although speciﬁc risk factors have been identiﬁed in both
hematopoietic stem cell transplant (HSCT) and solid organ
transplant (SOT) recipients, such as patient age, comorbidities,
conditioning regimen, cytomegalovirus (CMV) infection, renal
failure, and level of immunosuppression [1, 3], it is still difﬁ-
cult to accurately predict which patients will develop this com-
plication [4].
An increasing number of studies are highlighting a role for ge-
netic polymorphisms in susceptibility to invasive fungal infec-
tions [4]. So far, due to numerous limitations, existing data
have not supported the use of such polymorphisms for individual
risk stratiﬁcation in the clinical practice. A major limiting factor
is the inability to replicate the association, especially when studies
are performed in populations that differ in terms of baseline
characteristics or immunosuppressive regimen [4].
Pentraxin 3 (PTX3) is a soluble pattern recognition receptor
(PRR) produced by neutrophils, dendritic cells, macrophages,
and epithelial cells that has been shown to exert important an-
tifungal protection [5]. Polymorphisms in the PTX3 gene in the
donor have been recently associated with increased susceptibil-
ity to invasive aspergillosis (IA) among HSCT recipients [6].
Here, we show that polymorphisms in PTX3 also increase sus-
ceptibility to IMIs among SOT recipients. This observation
strengthens the role of PTX3 polymorphisms in immune de-
fenses against fungal pathogen and their potential use as a pre-
dictor for infection in clinical practice.
MATERIALS AND METHODS
Patients and Study Design
The Swiss Transplant Cohort Study (STCS) is a large national
cohort of SOT recipients followed at 6 Swiss university centers
[7, 8]. For the present study, SOT recipients enrolled prospec-
tively from May 2008 to December 2011 who provided written
informed consent for participation to genetic studies within the
STCS were included. The protocol was approved by the ethics
committees of all participating centers. Patients’ data were col-
lected at enrollment, at 6 months, and every 12 months after
transplantation on standardized case report forms. Mold colo-
nization and proven or probable IMI were diagnosed according
to European Organization for Research and Treatment of Can-
cer/Invasive Fungal Infections Cooperative Group and the Na-
tional Institute of Allergy and Infectious Diseases Mycoses Study
Group (EORTC/MSG) deﬁnitions as previously described [8, 9].
Only patients undergoing their ﬁrst organ transplant were in-
cluded. Patients who had mold infection before undergoing
transplantation (n = 5) were disqualiﬁed from the study.
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Genotyping
Genomic DNAwas extracted from patients’ blood using the Gen-
tra Puregene Blood Kit (Qiagen, Hombrechtikon, Switzerland).
Three single-nucleotide polymorphisms (SNPs) in PTX3, in-
cluding rs2305619 (+281A/G), rs1840680 (+1449A/G), and
rs3816527 (+734A/C [D48A]), were selected on the basis of pre-
vious observations [6]. The rs2305619 and rs1840680 SNPs
were genotyped as a part of a customized GoldenGate Genotyp-
ing Assay (BeadXpress, Veracode technology, Illumina). The
rs3816527 SNP was genotyped using competitive allele-speciﬁc
polymerase chain reaction (KASP, LGC Genomics, Hoddesdon,
Herts, United Kingdom).
Statistical Analysis
Statistical analysis was performed using Stata version 13.1 soft-
ware (StataCorp LP, College Station, Texas). The association be-
tweenmold colonization and IMI by PTX3 variants were assessed
by 36-month cumulative incident curves (with censoring at loss
to follow-up or death date) and by using the log-rank test [8].
Stepwise Cox regression model were used to estimate risk fac-
tors that were independently associated with the phenotypes.
Based on previous studies [6], the associations were tested for the
recessive mode of inheritance. Linkage disequilibrium andHardy–
Weinberg equilibrium were assessed using the pwld and hwe pro-
grams implemented in Stata. Because rs2305619 and rs1840680
were in almost perfect linkage disequilibrium (R2 = 0.99), analy-
ses are shown only for rs2305619. PTX3 haplotypes were gener-
ated using PHASE version 2.1 (University of Washington,
Seattle). Power calculation was performed using the powerSurvEpi
package 0.0.6 in R (R Core Team, Vienna, Austria).
RESULTS
The study included 1101 white patients who received an SOT
from kidney (n = 670), liver (n = 190), lung (n = 102), heart
(n = 79), islet/pancreas (n = 15), or combined organs (n = 45).
Among those, 45 were diagnosed with mold colonization (21
lung, 11 kidney, 7 heart, 4 liver, and 2 mixed organ recipients;
Supplementary Table 1), and 26 developed IMIs (11 kidney, 5
lung, 5 heart, 3 liver, and 2 mixed organ recipients). IMIs were
caused by Aspergillus species (n = 21 [81%]) or other fungi (Fu-
sarium [n = 2], Alternaria [n = 1], Zygomycetes [n = 1], and
mixed pathogens [Zygomycetes and Fusarium, n = 1]). The
PTX3 rs2305619 and rs3816527 SNPs had minor allele frequen-
cies (MAFs) of 0.48 and 0.42, respectively, and both were at
Hardy-Weinberg equilibrium (Supplementary Tables 2 and 3).
To assess the risk of mold colonization and IMI according to
PTX3 polymorphisms, we ﬁrst analyzed the 36-month cumula-
tive incidence of colonization and infection after transplanta-
tion in patients carrying the different genotypes/diplotypes.
These incidences were signiﬁcantly higher among patients
carrying the rs3816527 AA genotype compared with those car-
rying the CC or CA genotype (colonization, 0.0621 vs 0.0320, log-
rank test P = .03; IMI, 0.0394 vs 0.0166, P = .03; Figure 1A and
1B). Similar but less signiﬁcant associations were observed
when comparing patients carrying the rs2305619 GG genotype
with those carrying the AA or AG genotype (colonization
P = .09 and IMI P = .08; Supplementary Figure 1A and 1B) or
when comparing patients carrying the h2/h2 diplotype (com-
bining the minor alleles of both rs2305619 and rs3816527) with
the other diplotypes (colonization P = .08 and IMI P = .07; Sup-
plementary Figure 2A and 2B).
To determine whether the polymorphisms were independent
risk factors for the fungal phenotypes, we used multivariate
stepwise Cox regression models adjusted for all relevant covar-
iates. The associations between rs3816527 and fungal coloniza-
tion or infection were even more signiﬁcant after adjustment for
age and sex, CMV infection or disease, CMV serostatus, immu-
nosuppressive drugs, acute/chronic rejection, and/or type of
transplanted organ (colonization hazard ratio [HR], 2.57
[95% conﬁdence interval {CI}, 1.42–4.65], P = .002 and IMI
HR, 3.18 [95% CI, 1.45–6.98], P = .004; Supplementary Table 4).
Signiﬁcant associations were also observed for rs2305619 (col-
onization HR, 1.97 [95% CI, 1.06–3.58], P = .03 and IMI HR,
2.29 [95% CI, 1.04–5.03], P = .04; Supplementary Table 5)
and the h2/h2 diplotype (colonization HR, 2.06 [95% CI,
1.12–3.79], P = .02 and IMI HR, 2.43 [95% CI, 1.11–5.34],
P = .03; Supplementary Table 6).
Because the occurrence of colonization and IMIs was signiﬁ-
cantly higher among thoracic transplant recipients, we performed
a supplementary analysis that was limited to this group of patients.
The associations between PTX3 polymorphisms and fungal colo-
nization and infection were even stronger, especially for rs3816527
(log-rank test: colonization P = .002 and IMI P = .006; Figure 1C
and 1D; multivariate model: colonization HR, 3.64 [95% CI,
1.67–7.92], P = .001; IMI HR, 7.33 [95% CI, 1.86–28.9], P = .004;
Supplementary Table 4). Signiﬁcant associations were also ob-
served for rs2305619 (colonization HR, 2.74 [95% CI, 1.26–
5.96], P = .01 and IMI HR, 5.30 [95% CI, 1.41–19.9], P = .01;
Supplementary Figure 1C and 1D and Supplementary Table 5)
and for the h2/h2 diplotype (colonization HR, 3.06 [95% CI,
1.39–6.75], P = .006 and IMI HR, 5.68 [95% CI, 1.56–20.7], P =
.009; Supplementary Figure 2C and 2D, Supplementary Table 6).
DISCUSSION
A number of studies have reported associations between poly-
morphisms in host immune genes and susceptibility to fungal
infections in immunocompromised patients [4]. Many were
limited by several factors, including a lack of replication and/
or the absence of functional evidence supporting the association
[4]. Polymorphisms in PTX3 in the donor have been recently
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associated with an increased risk for the development of IA
among HSCT recipients [6]. We report for the ﬁrst time an as-
sociation between such polymorphisms and susceptibility to
mold colonization and IMIs among SOT recipients. Thus, the
validation in a different patient population suggests that PTX3
polymorphisms may represent a valuable marker of increased
risk for fungal infection.
The 2 PTX3 polymorphisms have a relatively high frequency
(MAF, approximately 0.4) [6] compared with polymorphisms
previously associated with IA, such as rs4986790/1 in Toll-
like receptor 4 (TLR4; MAF, approximately 0.05) [10] and
rs16910526 in Dectin-1 (MAF, 0.08) [11]. Rare SNPs require
very large cohorts for replication, whereas frequent ones can
be replicated in smaller datasets. The association between
PTX3 polymorphisms was initially replicated in 2 independent
cohorts of HSCT recipients from different centers [6]. In the
present study, we provide further validation in a population
whose clinical condition and type of immunosuppressive regi-
men is different. Thus, these polymorphisms may be more uni-
versal than other population-speciﬁc risk factors.
There is strong evidence for the involvement of PTX3 in the
immune responses against Aspergillus species [5]. PTX3 can di-
rectly bind Aspergillus conidia by recognizing galactomannan,
thereby acting as an opsonizing factor for complement activa-
tion and subsequent phagocytosis [12]. PTX3 can also interact
with PRRs such as Dectin-1 or TLR4 to increase fungal pattern
recognition and thus promote adaptive immune responses [12,
13]. In vivo, PTX3 knockout mice have been shown to be highly
susceptible to IA due to defective recognition of A. fumigatus by
macrophages and their phagocytic activities as well as imbal-
anced adaptive responses to this fungus [5].
In addition, there is evidence that polymorphisms in PTX3 are
associated with reduced immunity against fungal pathogens. The
missense +734A rs3816527 allele was suggested to inﬂuence
PTX3 messenger RNA stability, thereby affecting its secondary
structure and leading to its lower expression. PTX3 variants
were also associated with reduced PTX3 production in neutro-
phils with defective phagocytic activities and reduced Aspergillus
clearance [6].Of note, neutrophils originate from the donor stem
cells in HSCT and from the recipient in SOT. Consistently, poly-
morphisms associated with IA in the previous study of HSCT pa-
tients were issued from the donor [6], whereas those associated
with IMIs in the present study of SOT recipients are from the re-
cipient. As most patients who develop infection are previously
colonized, it is difﬁcult to determine whether the polymorphisms
inﬂuence colonization alone, or colonization and infection.
Figure 1. Cumulative incidence of mold colonization and invasive mold infection according to PTX3 rs3816527 single-nucleotide polymorphism in all (A
and B) and thoracic (C and D) solid organ transplant recipients. Patients who were colonized or infected with mold before transplantation were excluded
from the analyses. P values were calculated by log-rank test, recessive mode (patients homozygous for the rare alleles are compared to the others).
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Our ﬁndings indicate that speciﬁc genetic polymorphisms in
PTX3 are responsible for susceptibility to IMIs in SOT recipi-
ents. This study reinforces the validity of PTX3 polymorphisms
as an important risk factor for mold infection risk stratiﬁcation
in immunocompromised patients.
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